drugset / Trial / NCT02322216
Olopatadine Hydrochloride Ophthalmic Solution Study in Chinese Subjects
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to evaluate olopatadine 0.2% QD (once per day) compared to olopatadine 0.1% BID (twice per day) in the treatment of ocular itching associated with allergic conjunctivitis.
Timeline
- Start
- 2014-12
- Primary completion
- 2015-10
- Completion
- 2015-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Olopatadine | Other / unclassified | 0.1 % | Other |
| Subject | Olopatadine | Other / unclassified | 0.2 % | Other |